Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
McKesson
Baxter
Medtronic
McKinsey

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Gaboxadol

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Gaboxadol?

Gaboxadol is an investigational drug.

There have been 20 clinical trials for Gaboxadol. The most recent clinical trial was a Phase 3 trial, which was initiated on October 1st 2004.

The most common disease conditions in clinical trials are Sleep Initiation and Maintenance Disorders, Syndrome, and Angelman Syndrome. The leading clinical trial sponsors are H. Lundbeck A/S, Ovid Therapeutics Inc., and [disabled in preview].

Recent Clinical Trials for Gaboxadol
TitleSponsorPhase
A Phase 3 Study of OV101 in Pediatric Individuals With Angelman Syndrome (AS)Ovid Therapeutics Inc.Phase 3
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman SyndromeOvid Therapeutics Inc.Phase 2
A Study of OV101 in Individuals With Fragile X SyndromeOvid Therapeutics Inc.Phase 2

See all Gaboxadol clinical trials

Clinical Trial Summary for Gaboxadol

Top disease conditions for Gaboxadol
Top clinical trial sponsors for Gaboxadol

See all Gaboxadol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Harvard Business School
McKesson
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.